Loading clinical trials...
Loading clinical trials...
Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Cystic Neoplasms and Neuroendocrine Tumors
Conditions
Interventions
Endoscopic ultrasound-guided radiofrequency ablation for pancreatic cystic lesions
Endoscopic ultrasound-guided radiofrequency ablation of pancreatic solid lesions
Locations
1
Czechia
Institute for Clinical and Experimental Medicine, Department of Gastroenterology and Hepatology
Prague, Czechia
Start Date
April 11, 2026
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2029
Last Updated
April 17, 2026
NCT07274657
NCT02675738
Lead Sponsor
Institute for Clinical and Experimental Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions